BOLD Boundless Bio Forecast, Technical & Fundamental Analysis

a developer of gene therapy products for patients with serious rare diseases

Industry Biotechnology

Get AI intraday signals

BOLD

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For BOLD
(Try 14 days for Free)

View a ticker or compare two or three

Compare

BOLD

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For BOLD
(Try 14 days for Free)

Ad is loading...

A.I. Advisor

published Earnings

BOLD is expected to report earnings to rise 13.51% to -83 cents per share on February 26

Boundless Bio BOLD Stock Earnings Reports

Q4'24

Est.

$-0.84

Q3'24

Missed

by $0.01

Q2'24

Missed

by $0.12

The last earnings report on November 08 showed earnings per share of -74 cents, missing the estimate of -73 cents. With 71.84K shares outstanding, the current market capitalization sits at 55.75M.

A.I. Advisor

published General Information

General Information

a developer of gene therapy products for patients with serious rare diseases

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

9880 Campus Point Drive

Phone

+1 858 766-9912

Employees

Web

https://www.boundlessbio.com

Interesting Tickers

STOCK / NAME	Price $	Chg $	Chg %
		1 Day
GME	31.26	1.82	+6.18%
GameStop Corp
TSLA	479.86	16.84	+3.64%
Tesla
AAPL	253.48	2.44	+0.97%
Apple
BTC.X	106140.600000	110.890625	+0.10%
Bitcoin cryptocurrency
SPY	604.29	-2.50	-0.41%
SPDR® S&P 500® ETF Trust

BOLD and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, BOLD has been loosely correlated with KMSTF. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if BOLD jumps, then KMSTF could also see price increases.

Ticker / NAME	Correlation To BOLD	1D Price Change %
BOLD	100%	+0.80%
KMSTF - BOLD	56% Loosely correlated	N/A
KOD - BOLD	33% Loosely correlated	+9.24%
TNXP - BOLD	27% Poorly correlated	-37.00%
AKBA - BOLD	25% Poorly correlated	+1.63%
GRI - BOLD	20% Poorly correlated	+1.88%
More